Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0001511 (
Adhesion
)
5,955
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adhesion
ability of probiotics is the key factor that decides their colonization in the gastrointestinal tract and potential to inhibit pathogens. Therefore, adhesion ability can be considered as a key determinant for probiotic efficacy. Presents study documents the antagonistic activity of viable/untreated,
Lithium chloride (LiCl)
treated or heat-killed forms of eight probiotic
Lactobacillus reuteri
strains on the adhesion characteristics of selected pathogens. All strains investigated were able to adhere to Caco-2 cells.
L. reuteri
strains tested were able to inhibit and displace (
P
< 0.05) the adhesion of
Escherichia coli
ATCC25922,
Salmonella typhi
NCDC113,
Listeria monocytogenes
ATCC53135, and
Enterococcus faecalis
NCDC115. The probiotic strain
L. reuteri
LR6 showed the strongest adhesion and pathogen inhibition ability among the eight
L. reuteri
strains tested. In addition, the abilities to inhibit and to displace adhered pathogens depended on both the probiotic and the pathogen strains tested suggesting the involvement of various mechanisms. The adhesion and antagonistic potential of the probiotic strains were significantly decreased upon exposure to 5 M LiCl, showing that surface molecules, proteinaceous in nature, are involved. The heat-killed forms of the probiotic
L. reuteri
strains also inhibited the attachment of selected pathogens to Caco-2 cells. In conclusion,
in vitro
assays showed that
L. reuteri
strains, as viable or heat-killed forms, are adherent to Caco-2 cells and are highly antagonistic to pathogens tested in which surface associated proteins play an important role.
...
PMID:Antagonistic Activity of
Lactobacillus reuteri
Strains on the Adhesion Characteristics of Selected Pathogens. 2837 65